Sean M Oser, Melissa S Putman, Steven J Russell, Elizabeth B Westfeldt, Kelsey B Huss, Britney K Prince, Jessica A Parascando, Mollie Y O'Connor, Amy Sabean, Annabelle L Ashley, Evelyn G Greaux, Rachel J Bartholomew, Sarah Gaston, Nillani Anandakugan, Hui Zheng, Courtney A Balliro, Mallory A Hillard, Edward R Damiano, Tamara K Oser
{"title":"评估iLet仿生胰腺在初级保健和远程医疗中的应用：一项随机临床试验。","authors":"Sean M Oser, Melissa S Putman, Steven J Russell, Elizabeth B Westfeldt, Kelsey B Huss, Britney K Prince, Jessica A Parascando, Mollie Y O'Connor, Amy Sabean, Annabelle L Ashley, Evelyn G Greaux, Rachel J Bartholomew, Sarah Gaston, Nillani Anandakugan, Hui Zheng, Courtney A Balliro, Mallory A Hillard, Edward R Damiano, Tamara K Oser","doi":"10.2337/cd24-0104","DOIUrl":null,"url":null,"abstract":"<p><p>The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 3","pages":"388-398"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304562/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial.\",\"authors\":\"Sean M Oser, Melissa S Putman, Steven J Russell, Elizabeth B Westfeldt, Kelsey B Huss, Britney K Prince, Jessica A Parascando, Mollie Y O'Connor, Amy Sabean, Annabelle L Ashley, Evelyn G Greaux, Rachel J Bartholomew, Sarah Gaston, Nillani Anandakugan, Hui Zheng, Courtney A Balliro, Mallory A Hillard, Edward R Damiano, Tamara K Oser\",\"doi\":\"10.2337/cd24-0104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.</p>\",\"PeriodicalId\":39894,\"journal\":{\"name\":\"Clinical Diabetes\",\"volume\":\"43 3\",\"pages\":\"388-398\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304562/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2337/cd24-0104\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd24-0104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial.
The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.
期刊介绍：
The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
